EDIT vs PPL
Editas Medicine Inc (EDIT) versus PPL Corporation (PPL) — a side-by-side from cached financials, not a winner call.
Editas Medicine Inc (EDIT) is a biotechnology company listed on NASDAQ.
PPL Corporation (PPL) is a utilities - regulated electric company listed on NYSE.
Latest reported EDIT revenue for 2024-12-31 was $32.3M. Net income was -$237.1M. Revenue was down 58.6% from 2023-12-31 to 2024-12-31. EDIT currently screens at market cap $375.2M.
Latest reported PPL revenue for 2024-12-31 was $8.46B. Net income was $888.0M. Revenue was up 1.8% from 2023-12-31 to 2024-12-31. PPL currently screens at market cap $26.58B and trailing P/E 21.7.
EDIT currently screens at market cap $375.2M. PPL currently screens at market cap $26.58B and trailing P/E 21.7.
Not investment advice. Open the EDIT and PPL stock pages for the full models.
Not investment advice.